The impact of inflammation on hematopoietic stem cell specification
炎症对造血干细胞规范的影响
基本信息
- 批准号:9432324
- 负责人:
- 金额:$ 14.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-08 至 2022-09-07
- 项目状态:已结题
- 来源:
- 关键词:AddressAnemiaAnimal ModelAortaAwardBloodBlood CellsBone MarrowBone Marrow TransplantationCell LineageCell TherapyCellsCellular biologyClinicalCommunitiesConfocal MicroscopyCytokine ReceptorsDataDevelopmentDisciplineDorsalEmbryonic DevelopmentEndotheliumEnvironmentEventFocus GroupsFoundationsFutureGenerationsGenesGeneticGoalsHematological DiseaseHematologyHematopoieticHematopoietic Stem Cell ResearchHematopoietic Stem Cell TransplantationHematopoietic stem cellsHemoglobinopathiesHumanImageryImmunologicsImmunologyIn VitroIndividualInflammationInflammation MediatorsInflammatoryInstitutionJointsKnowledgeLaboratoriesLeadLifeMentorsMentorshipModelingMolecular BiologyMultipotent Stem CellsNF-kappa BNatural regenerationOrganismOutcomePGRN genePatientsPhasePlayPositioning AttributePostdoctoral FellowProcessPropertyProtocols documentationRecruitment ActivityRegulator GenesReportingResearchResearch PersonnelRoleSignal TransductionSorting - Cell MovementSourceSpecific qualifier valueStem cellsSystemTNF geneTechniquesTestingTherapeuticTo specifyTrainingTransgenic OrganismsWorkZebrafishbasecareercareer developmentcytokineexperimental studygenetic manipulationgenome editinghematopoietic stem cell fatehuman diseaseimprovedin vivoinduced pluripotent stem cellleukemiamutantnotch proteinnovelpgRNAreconstitutionscientific atmosphereself renewing cellskillsspatiotemporalsuccesstooltranscriptome sequencingvertebrate embryos
项目摘要
Hematopoietic stem cells (HSCs) are rare cells within human bone marrow that are responsible both for
the life-long replenishment of all blood cell lineages and for the curative effects of bone marrow transplantation.
The creation of human induced pluripotent stem cells holds great promise for cellular regeneration therapies, but
it is not currently possible to instruct these cells to generate HSCs in vitro. The goal of this application is to
determine how pro-inflammatory signaling via NF-kB instructs HSC fate in the vertebrate embryo, and how this
process is regulated by Progranulin a (Pgrna), with the ultimate goal of replicating HSC generation in vitro for
clinical utility. My working hypothesis is that early pro-inflammatory inputs converge to activate NF-kB, which in
turn activates key signaling events in the specification of HSC fate. These pro-inflammatory signals need to be
downregulated soon after HSC specification; my preliminary results suggest that Pgrna functions in this manner.
To test these hypotheses, this proposal consists of 2 aims: (1) Characterize the role of NF-kB in HSC
specification; and (2) identify the role of Pgrna in HSC emergence. This study will be conducted in zebrafish,
which are an ideal system for direct visualization of HSCs and have served as a model organism to study human
disease. To achieve this application’s goals, novel transgenic and mutant lines will be generated, and qPCR,
FACS-sorting, RNA-seq and confocal microscopy techniques will be utilized.
Dr. Espin Palazon is a postdoctoral fellow in David Traver’s laboratory at UCSD whose ultimate career
goal is to lead an independent research group focused on stem cells at a major research institution. Her short-
term goals are (1) to determine the spatiotemporal requirements of NF-kB within hemogenic endothelium, and
the downstream genes regulated to specify HSCs; and (2) to elucidate how Pgrna governs HSC emergence.
She was recruited to join Dr. Traver’s group because of her strong background in immunology and the zebrafish
animal model. The project outlined in this proposal will allow Dr. Espin Palazon to transition from a mentored
scientific position to an independent research career, helping her gain expertise in FACS sorting, RNA-seq,
genome editing techniques, and HSC biology, all of which are fundamental to establish her independent lab. Dr.
Espin Palazon will meet and present her work to experts in development, immunology and hematology, in
addition to presenting her data to a formal mentorship committee comprised of senior experts that will aid her
transition to an independent researcher. UCSD offers numerous courses that Dr. Espin Palazon will attend, as
well as seminars on career development and laboratory management. The vibrant, collaborative scientific
atmosphere at UCSD is an ideal environment for Dr. Espin Palazon to develop during the mentored phase of
her award, and will be instrumental in forming the foundation for the future success of these studies. She is well
poised to execute the proposed work, achieve her career development and training goals and to contribute high
impact research to the scientific community.
造血干细胞(HSC)是人类骨髓中稀有细胞,这两者都是
所有血细胞谱系的终身复制以及骨髓移植的治愈作用。
人类引起的多能干细胞的创建对细胞再生疗法具有巨大的希望,但
目前不可能指示这些细胞在体外产生HSC。该应用的目的是
通过NF-KB确定促炎性信号传导如何指示脊椎动物胚胎中的HSC命运,以及如何
过程受progranulin A(PGRNA)调节,其最终目标是在体外复制HSC生成
临床实用程序。我的工作假设是,早期的促炎性输入会融合激活NF-KB,这在
在HSC命运的规范中激活关键信号事件。这些促炎性信号必须是
HSC规格后不久下调;我的初步结果表明,PGRNA以这种方式起作用。
为了检验这些假设,该提案由2个目的组成:(1)表征NF-KB在HSC中的作用
规格; (2)确定PGRNA在HSC出现中的作用。这项研究将在斑马鱼进行
这是直接可视化HSC的理想系统,并已成为研究人类的模型生物
疾病。为了实现该应用程序的目标,将产生新颖的转基因和突变线,qpcr,
将利用FACS分级,RNA-SEQ和共聚焦显微镜技术。
Espin Palazon博士是UCSD的David Traver实验室的博士后研究员,他的最终职业生涯
目标是领导一个专注于主要研究机构干细胞的独立研究小组。她的短暂
术语目标是(1)确定血液内皮内NF-KB的时空要求,并且
调节的下游基因指定HSC; (2)阐明PGRNA如何控制HSC出现。
由于她的免疫学背景和斑马鱼,她被招募加入Traver博士的小组
动物模型。本提案中概述的项目将使Espin Palazon博士从事过渡
独立研究职业的科学地位,帮助她获得FACS分类的专业知识,RNA-Seq,
基因组编辑技术和HSC生物学,所有这些都是建立其独立实验室的基础。博士
Espin Palazon将与发展,免疫学和血液学专家见面并介绍她的工作,
除了将她的数据介绍给正式的高级委员会委员会完成,以帮助她
过渡到独立研究人员。 UCSD提供了许多Espin Palazon博士将参加的课程,
以及关于职业发展和实验室管理的半小伙子。充满活力的协作科学
UCSD的气氛是Espin Palazon博士在指导阶段发展的理想环境
她的奖项将有助于为这些研究的未来成功奠定基础。她很好
中毒以执行拟议的工作,实现她的职业发展和培训目标,并贡献很高
影响科学界的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Raquel Espín Palazón其他文献
Raquel Espín Palazón的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Raquel Espín Palazón', 18)}}的其他基金
Molecular dissection of Hematopoietic Stem Cell specification triggered by inflammatory mediators
炎症介质触发造血干细胞规范的分子解剖
- 批准号:
10552605 - 财政年份:2022
- 资助金额:
$ 14.65万 - 项目类别:
Molecular dissection of Hematopoietic Stem Cell specification triggered by inflammatory mediators
炎症介质触发造血干细胞规范的分子解剖
- 批准号:
10346708 - 财政年份:2022
- 资助金额:
$ 14.65万 - 项目类别:
In vivo assessment of granulin dependent myeloid cell formation
颗粒蛋白依赖性骨髓细胞形成的体内评估
- 批准号:
10201594 - 财政年份:2020
- 资助金额:
$ 14.65万 - 项目类别:
In vivo assessment of granulin dependent myeloid cell formation
颗粒蛋白依赖性骨髓细胞形成的体内评估
- 批准号:
10043081 - 财政年份:2020
- 资助金额:
$ 14.65万 - 项目类别:
The impact of inflammation on hematopoietic stem cell specification
炎症对造血干细胞规范的影响
- 批准号:
10475908 - 财政年份:2017
- 资助金额:
$ 14.65万 - 项目类别:
The impact of inflammation on hematopoietic stem cell specification
炎症对造血干细胞规范的影响
- 批准号:
10016274 - 财政年份:2017
- 资助金额:
$ 14.65万 - 项目类别:
The impact of inflammation on hematopoietic stem cell specification
炎症对造血干细胞规范的影响
- 批准号:
10242117 - 财政年份:2017
- 资助金额:
$ 14.65万 - 项目类别:
相似国自然基金
探究引起范科尼贫血症的内源DNA损伤
- 批准号:32371353
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
红系造血岛巨噬细胞TLR8信号激活在再生障碍性贫血中机制研究
- 批准号:82370144
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
偶氮苯连接双地拉罗司荧光共振能量转移开关祛铁剂的构建及用于β-地中海贫血铁负荷的检测和清除
- 批准号:82360706
- 批准年份:2023
- 资助金额:31 万元
- 项目类别:地区科学基金项目
限食通过下调MS4A3促进红细胞生成的机制研究及其在贫血人群中的临床运用
- 批准号:82360027
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
骨髓树突状细胞TLR1/2/8-MyD88通路在再生障碍性贫血发生发展中的作用
- 批准号:82370142
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Dietary regulation of type 2 immunity and inflammation in the gut
肠道 2 型免疫和炎症的饮食调节
- 批准号:
10740269 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别:
Small Molecule Therapeutics for Sickle Cell Anemia
镰状细胞性贫血的小分子疗法
- 批准号:
10601679 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别:
Iron homeostasis and monocyte differentiation in patients with chronic kidney disease
慢性肾病患者的铁稳态和单核细胞分化
- 批准号:
10648527 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别:
Molecular Basis for Myelodysplasia Induced by U2AF1 Mutations
U2AF1 突变诱导的骨髓增生异常的分子基础
- 批准号:
10649974 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别:
Specificity of RPSA-dependent translational control in mouse and human fetal spleen cells
小鼠和人胎儿脾细胞中 RPSA 依赖性翻译控制的特异性
- 批准号:
10647605 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别: